#RareDiseases #LifeSciencesSectorPlan #UKlifesciences #lifesciences #biotech #UKbiotechsector #orphanmedicines #NHSpatients #rarediseasetreatments #lifesciencesinvestment #EFPIA #innovationpathway #healthsystemreadiness #UKBioIndustryAssociation #ABPI #innovativetherapies
zurl.co/Q3pQV